Burgundy Asset Management Ltd. Decreases Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Burgundy Asset Management Ltd. decreased its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 9.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,668,899 shares of the company's stock after selling 167,353 shares during the quarter. Burgundy Asset Management Ltd. owned approximately 1.34% of Henry Schein worth $115,488,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Ananym Capital Management LP bought a new position in shares of Henry Schein during the fourth quarter valued at $32,628,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Henry Schein by 1.5% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 906,304 shares of the company's stock valued at $62,716,000 after buying an additional 13,618 shares during the last quarter. Worldquant Millennium Advisors LLC purchased a new stake in shares of Henry Schein during the fourth quarter valued at $2,308,000. Two Sigma Investments LP boosted its position in shares of Henry Schein by 216.6% during the fourth quarter. Two Sigma Investments LP now owns 30,709 shares of the company's stock valued at $2,125,000 after buying an additional 21,009 shares during the last quarter. Finally, Tidal Investments LLC boosted its position in shares of Henry Schein by 8.4% during the fourth quarter. Tidal Investments LLC now owns 15,113 shares of the company's stock valued at $1,046,000 after buying an additional 1,171 shares during the last quarter. Institutional investors own 96.62% of the company's stock.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares of the company's stock, valued at $4,460,251.20. This represents a 6.05% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the company's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares in the company, valued at $1,762,147.20. This trade represents a 9.50% decrease in their position. The disclosure for this sale can be found here. 1.08% of the stock is currently owned by corporate insiders.

Henry Schein Trading Up 2.8%

NASDAQ:HSIC traded up $2.01 during midday trading on Tuesday, hitting $73.66. 1,915,580 shares of the company traded hands, compared to its average volume of 1,663,158. The firm's fifty day moving average is $67.47 and its 200-day moving average is $71.56. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49. The firm has a market capitalization of $8.97 billion, a P/E ratio of 30.31, a P/E/G ratio of 2.13 and a beta of 0.87. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.11 by $0.04. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein's quarterly revenue was down .1% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.10 EPS. On average, sell-side analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. Piper Sandler dropped their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 30th. UBS Group lowered their price objective on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Barrington Research lowered their price objective on Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 6th. Wells Fargo & Company lowered their price objective on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Finally, Wall Street Zen cut Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Henry Schein has an average rating of "Moderate Buy" and a consensus price target of $79.30.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.